Robert E. Miller - Publications, H-index & Citations

Robert E. Miller

lund university

56H指数

356论文数

1.6W被引数

收录论文 45

发表时间

Practice Guidelines for Teledermatology in Australia: 2025 Update 澳大利亚远程皮肤病学实践指南：2025年更新

AUSTRALASIAN JOURNAL OF DERMATOLOGY

IF1.8

2025-09-01

OAAI

Caffery, Liam J.; Taylor, Monica L.; Abbott, Lisa M.; Janda, Monika; Guitera, Pascale; Mar, Victoria; Bennett, Haley; Arnold, Chris; Shumack, Stephen; Caccetta, Tony; Miller, Robert; Soyer, H. Peter

Intercellular Adhesion Molecule 1 (ICAM-1): An Inflammatory Regulator with Potential Implications in Ferroptosis and Parkinson's Disease 细胞间粘附分子1 (ICAM-1): 在铁死亡和帕金森氏病中具有潜在意义的炎症调节剂

CELLS

IF5.2

2024-09-15

OAAI

Miller, Matthew R.; Landis, Harold E.; Miller, Robert E.; Tizabi, Yousef

The Bispecific Tumor Antigen-Conditional 4-1BB x 5T4 Activation and Potent Antitumor Activity in Preclinical Studies

MOLECULAR CANCER THERAPEUTICS

IF5.5

2022-11-07

OAAI

Nelson, Michelle H.; Fritzell, Sara; Miller, Robert; Werchau, Doreen; Van Citters, Danielle; Nilsson, Anneli; Misher, Lynda; Ljung, Lill; Bader, Robert; Deronic, Adnan; Chunyk, Allison G.; Schultz, Lena; Varas, Laura A.; Rose, Nadia; Hakansson, Maria; Gross, Jane; Furebring, Christina; Pavlik, Peter; Sundstedt, Anette; Veitonmaki, Niina; Ramos, Hilario J.; Sall, Anna; Dahlman, Anna; Bienvenue, David; von Schantz, Laura; McMahan, Catherine J.; Askmyr, Maria; Hernandez-Hoyos, Gabriela; Ellmark, Peter

College students and inappropriate social media posting: Is it a question of personality or the influence of friends?

PERSONALITY AND INDIVIDUAL DIFFERENCES

IF2.6

2020-05-01

PREAI

Miller, Robert E.

ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach

ANNALS OF ONCOLOGY

IF65.4

2019-08-01

668

OAAI

Luchini, C.; Bibeau, F.; Ligtenberg, M. J. L.; Singh, N.; Nottegar, A.; Bosse, T.; Miller, R.; Riaz, N.; Douillard, J. -Y.; Andre, F.; Scarpa, A.

APVO436, a bispecific anti-CD123 x anti-CD3 ADAPTIR® molecule for redirected T-cell cytotoxicity, induces potent T-cell activation, proliferation and cytotoxicity with limited cytokine release

CANCER RESEARCH

IF16.6

2018-07-01

PREAI

Comeau, Michael R.; Miller, Robert E.; Bader, Robert; Gottschalk, Rebecca; Daugherty, Mollie; Sewell, Toddy; Misher, Lynda; Parr, Lara; DeFrancesco, Melissa; Bienvenue, David; McMahan, Catherine J.; Hoyos, Gabriela H.; Gross, Jane A.

Characterization of APVO436, a bispecific anti-CD123 x anti-CD3 ADAPTIR™ molecule for redirected T-cell cytotoxicity, in preclinical models of AML and nonhuman primates

MOLECULAR CANCER THERAPEUTICS

IF5.5

2018-01-01

PREAI

Comeau, Michael R.; Miller, Robert E.; Bannink, Jeannette; Johnson, Starrla; Bader, Robert; Gottschalk, Rebecca; Misher, Lynda; Mitchell, Danielle; Parr, Lara; DeFrancesco, Melissa; Bienvenue, David; McMahan, Catherine J.; Hoyos, Gabriela H.; Gross, Jane A.

Bispecific anti-CD123 x anti-CD3 ADAPTIR™ molecules for redirected T-cell cytotoxicity in hematological malignancies

CANCER RESEARCH

IF16.6

2017-07-01

PREAI

Comeau, Michael R.; Mitchell, Danielle; Gottschalk, Rebecca; Misher, Lynda; Daugherty, Mollie; Parr, Lara; Pavlik, Peter; Woodruff, Brian; Fang, Hang; Aguilar, Megan; Bannink, Jeannette; Johnson, Starrla; Li, Gary; Miller, Robert E.; Bader, Robert; Zhang, Nicole; Sewell, Toddy; Dasovich, Maria; Hoyos, Gabriela H.; Blankenship, John W.; McMahan, Catherine; Bienvenue, David; Gross, Jane A.

MOR209/ES414, a Novel Bispecific Antibody Targeting PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer

MOLECULAR CANCER THERAPEUTICS

IF5.5

2016-09-01

OAAI

Hernandez-Hoyos, Gabriela; Sewell, Toddy; Bader, Robert; Bannink, Jeannette; Chenault, Ruth A.; Daugherty, Mollie; Dasovich, Maria; Fang, Hang; Gottschalk, Rebecca; Kumer, John; Miller, Robert E.; Ravikumar, Padma; Wiens, Jennifer; Algate, Paul A.; Bienvenue, David; McMahan, Catherine J.; Natarajan, Sateesh K.; Gross, Jane A.; Blankenship, John W.

anti-ROR1 x anti-CD3 ADAPTIRTm molecule, ES425, redirects T-cell cytotoxicity and inhibits tumor growth in preclinical models of triple negative breast cancer

CANCER RESEARCH

IF16.6

2016-07-15

PREAI

Blankenship, John W.; Misher, Lynda; Mitchell, Danielle; Zhang, Nicole; Tan, Philip; Hoyos, Gabriela H.; Ravikumar, Padma; Bader, Robert; McMahan, Catherine J.; Miller, Robert E.; Bannink, Jeannette; Fang, Hang; Parr, Lara; Dasovich, Maria; Bienvenue, David; Aguilar, Megan; Xu, Carina; Daugherty, Mollie; Woodruff, Brian; Gross, Jane A.

Chemotherapy for metastatic castrate-sensitive prostate cancer

PROSTATE CANCER AND PROSTATIC DISEASES

IF5.8

2016-03-15

OAAI

Miller, R. E.; Sweeney, C. J.

Impact of different methods of feedback to clinicians after postprescription antimicrobial review based on the Centers for Disease Control and Prevention's 12 steps to prevent antimicrobial resistance among hospitalized adults

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

IF3

2015-01-02

PREAI

Cosgrove, Sara E.; Patel, Alpa; Song, Xiaoyan; Miller, Robert E.; Speck, Kathleen; Banowetz, Amy; Hadler, Rachel; Sinkowitz-Cochran, Ronda L.; Cardo, Denise M.; Srinivasan, Arjun

Combined therapy with the RANKL inhibitor RANK-Fc and rhApo2L/TRAIL/dulanermin reduces bone lesions and skeletal tumor burden in a model of breast cancer skeletal metastasise

CANCER BIOLOGY & THERAPY

IF4.6

2014-10-27

OAAI

Holland, Pamela M.; Miller, Robert; Jones, Jon; Douangpanya, Heather; Piasecki, Julia; Roudier, Martine; Dougall, William C.

RANK expression on breast cancer cells promotes skeletal metastasis 乳腺癌细胞RANK表达促进骨骼转移

CLINICAL & EXPERIMENTAL METASTASIS

IF3.2

2013-11-24

PREAI

Blake, Michelle L.; Tometsko, Mark; Miller, Robert; Jones, Jon C.; Dougall, William C.

Inhibition of RANKL increases the anti-tumor effect of the EGFR inhibitor panitumumab in a murine model of bone metastasis

BONE

IF3.6

2010-06-01

PREAI

Canon, Jude; Bryant, Rebecca; Roudier, Martine; Osgood, Tao; Jones, Jon; Miller, Robert; Coxon, Angela; Radinsky, Robert; Dougall, William C.

Identification of I Kr Kinetics and Drug Binding in Native Myocytes

ANNALS OF BIOMEDICAL ENGINEERING

IF5.4

2009-04-08

OAAI

Zhou, Qinlian; Zygmunt, Andrew C.; Cordeiro, Jonathan M.; Siso-Nadal, Fernando; Miller, Robert E.; Buzzard, Gregery T.; Fox, Jeffrey J.

A world wide web-based antimicrobial stewardship program improves efficiency, communication, and user satisfaction and reduces cost in a tertiary care pediatric medical center

CLINICAL INFECTIOUS DISEASES

IF7.3

2008-09-15

PREAI

Agwu, Allison L.; Lee, Carlton K. K.; Jain, Sanjay K.; Murray, Kara L.; Topolski, Jason; Miller, Robert E.; Townsend, Timothy; Lehmann, Christoph U.

RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis

MOLECULAR CANCER THERAPEUTICS

IF5.5

2008-07-21

OAAI

Miller, Robert E.; Roudier, Martine; Jones, Jon; Armstrong, Allison; Canon, Jude; Dougall, William C.

The RANKL inhibitor OPG-Fc delays the de novo establishment of breast cancer skeletal metastases in an MDA-MB-231 mouse model

CANCER TREATMENT REVIEWS

IF10.5

2008-01-01

PREAI

Canon, Jude; Bryant, Rebecca; Miller, Robert; Erwert, Ryan; Roudier, Martine; Coxon, Angela; Dougall, William

Receptor activator of NF-κB ligand inhibition suppresses bone resorption and Hypercalcemia but does not affect host immune responses to influenza infection

JOURNAL OF IMMUNOLOGY

IF3.4

2007-07-01

OAAI

Miller, Robert E.; Branstetter, Daniel; Armstrong, Allison; Kennedy, Bryan; Jones, Jon; Cowan, Laine; Bussiere, Jeanine; Dougall, William C.

研究方向